Robert J Hayashi
Overview
Explore the profile of Robert J Hayashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
1456
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barnett S, Malone S, Strelnikov J, LHotta A, Zabotka L, Lueder G, et al.
Rare Tumors
. 2024 Dec;
16:20363613241306191.
PMID: 39665086
Pediatric retinoblastoma survivors exhibit visual deficits. How these visual deficits impact reading skills is unknown. The purpose of this study is to assess reading level, reading acuity, and reading speed...
2.
Kahn J, Brazauskas R, Bo-Subait S, Buchbinder D, Hamilton B, Schoemans H, et al.
Lancet Child Adolesc Health
. 2024 Sep;
8(10):740-750.
PMID: 39217999
Background: Continued advances in haematopoietic cell transplantation (HCT) for children with non-malignant diseases (NMDs) have led to a growing population of survivors in whom late occurring toxic effects remain a...
3.
Allen U, LHuillier A, Bollard C, Gross T, Hayashi R, Hocker B, et al.
Pediatr Transplant
. 2024 May;
28(5):e14781.
PMID: 38808744
The International Pediatric Transplant Association convened an expert consensus conference to assess current evidence and develop recommendations for various aspects of care relating to post-transplant lymphoproliferative disorders (PTLD) after pediatric...
4.
LHotta A, Spence A, Varughese T, Felts K, Hayashi S, Jones-White M, et al.
Front Pediatr
. 2024 Apr;
12:1341762.
PMID: 38571700
Background: Childhood cancer survivors (CCS) with chemotherapy induced sensorineural hearing loss (SNHL) are at risk for neurocognitive impairments. The purpose of this study was to determine the relationship between SNHL...
5.
Jakubiak J, Guan M, Khan S, Fowler L, Bates C, King A, et al.
Clin Pract Pediatr Psychol
. 2024 Apr;
12(1):93-103.
PMID: 38559896
Objective: Understand the perspectives of children who survived acute lymphoblastic leukemia (ALL) and their parents to adapt a guideline-based, family-based, intensive health behavior and lifestyle intervention treatment for this population....
6.
Spence A, LHotta A, Hayashi S, Felts K, LaFentres E, Jones-White M, et al.
Front Oncol
. 2024 Mar;
14:1362315.
PMID: 38511136
Background: Childhood cancer survivors (CCS) exposed to platinum chemotherapy are at an increased risk of developing hearing loss and reporting decreased quality of life (QOL). This study compared two QOL...
7.
Hayashi R, Hermiston M, Wood B, Teachey D, Devidas M, Chen Z, et al.
Blood
. 2024 Mar;
143(20):2053-2058.
PMID: 38457359
Defining prognostic variables in T-lymphoblastic lymphoma (T-LL) remains a challenge. AALL1231 was a Children's Oncology Group phase 3 clinical trial for newly diagnosed patients with T acute lymphoblastic leukemia or...
8.
Alexander S, Harker-Murray P, Hayashi R
Front Immunol
. 2024 Mar;
15:1379278.
PMID: 38449864
No abstract available.
9.
van der Plas E, Darji H, Srivastava D, Schapiro M, Jeffe D, Perkins S, et al.
Cancer
. 2024 Feb;
130(12):2224-2236.
PMID: 38373075
Background: Prevalence and risk of poor psychological outcomes following rhabdomyosarcoma (RMS) are not well-established. Methods: Participants in this cross-sectional, case-control study (n = 713 survivors, 42.5% female; mean [SD] age,...
10.
Rotz S, Hamilton B, Wei W, Ahmed I, Winston S, Ballard S, et al.
Transplant Cell Ther
. 2024 Feb;
30(5):534.e1-534.e13.
PMID: 38342136
The use of reduced-intensity conditioning (RIC) regimens has increased in an effort to minimize hematopoietic stem cell transplantation (HCT) end-organ toxicity, including gonadal toxicity. We aimed to describe the incidence...